The Scan by 2 Minute Medicine®: Fibroids, Fatigue, Tainted Syrups, and Bariatric Barriers

Venus Williams reignites the fibroid fight with a comeback and a cause

Recently, Venus Williams stunned fans by revealing that her return to professional tennis at age 45 was driven partly by the need to regain health insurance. As People reported, she had lost her coverage during a break from the Women’s Tennis Association and rejoined the circuit to requalify. Behind that decision is a more personal struggle: her long‑standing battle with uterine fibroids, a condition that disproportionately impacts Black women. A review in Nature Reviews Endocrinology published on July 17 found that up to 80 percent of Black women will develop fibroids by age 50. Community groups such as the Resilient Sisterhood Project and academic centers like Michigan Medicine describe how racial disparities in treatment persist, with Black women more likely to be offered hysterectomy and less likely to receive uterine‑sparing options such as uterine‑artery embolization. Williams has spoken about managing intense pain, fatigue, and anemia during matches—symptoms that are often dismissed or under‑diagnosed. Her recent win at the DC Open made her the oldest woman to win a WTA match since 2004, underscoring not only her athletic resilience but also her commitment to increasing visibility for overlooked women’s‑health issues. Her story also highlights how even world‑class athletes are vulnerable to the gaps in insurance coverage that affect millions of Americans. Next, we turn to a public figure navigating a different kind of chronic condition: the long shadow of COVID.

Matt McGorry joins NYC’s long COVID wave as new science shifts the narrative

Matt McGorry, known for Orange Is the New Black, opened up this week about his experience living with long COVID, joining tens of thousands in New York struggling with persistent symptoms. A July 25 report in the New York Post detailed his fatigue, brain fog, and respiratory issues that have lingered for more than 18 months. According to the NYC Department of Health, more than 21,800 New Yorkers have enrolled in its Long COVID AfterCare hub, with over 25 percent of COVID survivors reporting symptoms that interfere with daily life. This public awareness intersects with new biological research published on July 22, when a Nature Medicine study analyzed blood samples from 6,574 individuals and identified four distinct subtypes of long COVID. Patient advocates like McGorry, who supports initiatives such as Body Politic, are calling for research funding, disability protections, and insurance coverage for long‑COVID treatment. As this condition continues to affect millions globally, the study marks a turning point for designing targeted interventions and validating patient experiences. From invisible symptoms to invisible toxins, our next story moves to a global crisis in medicine safety.

WHO slams weak drug oversight after more than 300 children die from tainted syrups

On July 24, the World Health Organization and UN Office on Drugs and Crime issued a joint warning after over 300 children died from contaminated over‑the‑counter medicines, mostly in Africa and Asia. These deaths have been linked to cold‑ and fever‑syrups containing industrial chemicals like diethylene glycol and ethylene glycol—compounds used in antifreeze that are fatal when ingested. According to a Reuters investigation, the syrups were manufactured by companies in India and Indonesia and distributed through under‑regulated supply chains that lacked independent quality testing. The WHO alert, listed in its medical‑product‑alerts database, criticized national regulators for relying solely on supplier‑provided certificates and highlighted the role of online pharmacies in making traceability even more difficult. Officials are now urging countries to implement routine batch testing, public product‑alert systems, and clear adverse‑event reporting mechanisms to prevent further deaths. The tragedy highlights a global failure in pharmaceutical governance and disproportionately affects children in low‑resource countries without stringent regulatory infrastructure. International agencies are calling for an overhaul in how medicines are verified, sourced, and sold across borders.

Tammy Slaton’s 500-pound weight loss spotlights access gaps in bariatric care

Tammy Slaton, the reality‑television star of 1000‑Lb Sisters, revealed a dramatic 500‑pound weight loss this week, drawing attention to her two‑year journey through bariatric surgery and rehabilitation. On July 24, Slaton shared photos that went viral and reflected the culmination of major lifestyle changes, emotional loss, and medical milestones. People reports she was previously oxygen‑dependent and required extensive pre‑op counseling before qualifying for surgery in 2022. At her heaviest, she weighed more than 700 pounds and could not walk unassisted. An E! Online feature chronicled her recent skin‑removal surgery, while Hello! highlighted how her visibility reshaped public perception. The American Society for Metabolic and Bariatric Surgery notes that over 260,000 Americans undergo bariatric procedures annually, yet insurance denials, stigma, and rigid clinical criteria exclude many who would benefit. Slaton’s televised experience provided rare transparency into the hurdles faced both before and after surgery, including body‑image challenges, comorbidity management, and access to skin‑removal surgery. Her journey reinforces the need to treat obesity as a chronic condition, not a personal failure, and has reignited calls for more equitable access to comprehensive obesity care in the United States.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.